Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd. has successfully raised A$3.1 million from institutional investors through a 1 for 1.82 accelerated non-renounceable entitlement offer, contributing to their total A$10.0 million equity raising goal. The company is now set to open a retail entitlement offer aiming to raise an additional A$6.9 million. The proceeds from these offers are earmarked for the completion of a CLIA waiver trial in the US, product development, sales, marketing, and general working capital.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
